AU1407197A - Stable vancomycin hydrochloride solutions - Google Patents

Stable vancomycin hydrochloride solutions

Info

Publication number
AU1407197A
AU1407197A AU14071/97A AU1407197A AU1407197A AU 1407197 A AU1407197 A AU 1407197A AU 14071/97 A AU14071/97 A AU 14071/97A AU 1407197 A AU1407197 A AU 1407197A AU 1407197 A AU1407197 A AU 1407197A
Authority
AU
Australia
Prior art keywords
vancomycin hydrochloride
hydrochloride solutions
stable vancomycin
stable
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14071/97A
Other languages
English (en)
Inventor
Robert L. Robison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9600213.4A external-priority patent/GB9600213D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1407197A publication Critical patent/AU1407197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU14071/97A 1995-12-01 1996-11-25 Stable vancomycin hydrochloride solutions Abandoned AU1407197A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US782495P 1995-12-01 1995-12-01
US007824 1995-12-01
GB9600213 1996-01-05
GBGB9600213.4A GB9600213D0 (en) 1996-01-05 1996-01-05 Stable vancomycin hydrochloride solutions
PCT/US1996/018898 WO1997019690A1 (fr) 1995-12-01 1996-11-25 Solutions stables d'hydrochlorure de vancomycine

Publications (1)

Publication Number Publication Date
AU1407197A true AU1407197A (en) 1997-06-19

Family

ID=26308428

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14071/97A Abandoned AU1407197A (en) 1995-12-01 1996-11-25 Stable vancomycin hydrochloride solutions

Country Status (3)

Country Link
AU (1) AU1407197A (fr)
CA (1) CA2238872A1 (fr)
WO (1) WO1997019690A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999017793A1 (fr) * 1997-10-03 1999-04-15 Fujisawa Pharmaceutical Co., Ltd. Chlorhydrates de vancomycines antibiotiques et leur procede de production
ES2903419T3 (es) 2014-03-14 2022-04-01 Azurity Pharmaceuticals Inc Composición y método para líquido oral de vancomicina
AU2015341763B2 (en) 2014-11-06 2019-01-17 Xellia Pharmaceuticals Aps Glycopeptide compositions
CN107106585B (zh) * 2015-02-06 2021-01-01 杭州美南医药科技有限公司 万古霉素的水溶液制剂
SG11201809908TA (en) 2016-05-09 2018-12-28 Xellia Pharmaceuticals Aps Stabilized glycopeptide antibiotic formulations
CA3132923A1 (fr) 2019-03-08 2020-09-17 Emphascience, Inc. Formulations pharmaceutiques stables de medicaments peptidiques et proteiques
US11433115B2 (en) 2020-10-30 2022-09-06 Somerset Therapeutics, Llc Glycopeptide antibiotics liquid formulations and methods and uses thereof
EP4014969A1 (fr) 2020-12-16 2022-06-22 EVER Valinject GmbH Solution aqueuse
EP4014965A1 (fr) 2020-12-16 2022-06-22 EVER Valinject GmbH Solution aqueuse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885275A (en) * 1987-10-15 1989-12-05 Eli Lilly And Company Vancomycin-HCL solutions and the lyophilization thereof

Also Published As

Publication number Publication date
CA2238872A1 (fr) 1997-06-05
WO1997019690A1 (fr) 1997-06-05

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU1407197A (en) Stable vancomycin hydrochloride solutions
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5693596A (en) Active compound combinations
AU4382896A (en) Acetylimidazobenzodiazepines
AU5500196A (en) Anti-transpirants
AU6473496A (en) Retention agent
AU5108596A (en) Morphine-3-esters
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU5002196A (en) Immunosuppressive agents
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU1093697A (en) Active bio-compounds
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU7693696A (en) Endoparasiticidal agents
AU6369996A (en) Anti-piroplasmotic agent
AU4783896A (en) Active bio-compounds
AU2161897A (en) Helicopter-airplane
AU4531096A (en) Foodpellet